NASDAQ:IRD | Free Cash Flow | Opus Genetics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2009-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$12.73M
2025-12-31-$9.83M
2025-03-31-$8.99M
2024-12-31-$7.44M
2024-03-31-$5.72M
2023-12-31$4.55M
2023-03-31-$3.65M
2022-12-31$28.79M
2022-03-31-$6.17M
2021-12-31-$5.65M
2021-03-31-$5.81M
2020-12-31-$4.36M
2020-03-31-$732,000.00
2019-12-31$4.97M
2019-03-31-$4.38M
2018-12-31-$4.62M
2018-03-31-$5.6M
2017-12-31-$3.7M
2017-03-31-$4.17M
2016-12-31-$1.49M
2016-03-31-$3.55M
2015-12-31-$4.41M
2015-03-31-$4.04M
2014-12-31-$2.91M
2014-03-31-$2.58M
2013-12-31-$2.25M
2013-03-31-$1.55M
2012-12-31-$1.07M
2012-03-31-$1.92M
2011-12-31-$4.88M
2011-03-31-$2.43M
2010-12-31-$2.42M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$35.25M
2024-12-31-$25.58M
2023-12-31-$1.11M
2022-12-31$14.31M
2021-12-31-$19.37M
2020-12-31-$6.8M$0.00-$6.8M
2019-12-31-$3.59M$25,000.00-$3.62M
2018-12-31-$18.84M
2017-12-31-$15.42M
2016-12-31-$13.23M
2015-12-31-$17.35M
2014-12-31-$11.04M
2013-12-31-$7.98M
2012-12-31-$6.62M
2011-12-31-$15.53M
2010-12-31-$6.99M
2009-12-31-$5.15M